SCHEMBL1836733

SCHEMBL1836733

O=C1CSC(=S)N1Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.51
GAA P10253 8/20 0.51
ALDH1A1 P00352 6/20 0.50
KMT2A Q03164 6/20 0.50
TDP1 Q9NUW8 4/20 0.50
RECQL P46063 3/20 0.50
CASP6 P55212 2/20 0.50
KDM4E B2RXH2 2/20 0.50
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ALPL P05186 1/20 0.50
ALPI P09923 1/20 0.50
ALPG P10696 1/20 0.50
PLCG1 P19174 1/20 0.50
THRB P10828 1/20 0.50
GSK3A P49840 4/20 0.49
GSK3B P49841 4/20 0.49
CYP1A2 P05177 1/20 0.46
MEN1 O00255 5/20 0.44
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3037541 0.83 MAPT (0.55) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL3040357 0.81 KMT2A (0.60) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL6002938 0.79 MAPT (0.43) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL9097624 0.78 GAA (0.50) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL3030170 0.77 MAPT (0.55) MAPTGAAALDH1A1KMT2ATDP1
N-Benzoylaminorhodanine SCHEMBL8595198 0.74 MAPT (0.74) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL6783895 0.74 MAPT (0.50) MAPTGAAALDH1A1KMT2ATDP1
SCHEMBL4394297 0.71 CYP1A2 (0.57) MAPTGAAALDH1A1TDP1CASP6
SCHEMBL181796 0.69 KMT2A (0.69) MAPTGAAALDH1A1KMT2ARECQL
SCHEMBL9667997 0.69 CYP1A2 (0.46) MAPTGAAALDH1A1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4450159-A ORGAN TRANSPLANTS; IMMUNOLOGY THE UPJOHN COMPANY (US) 1984-05-22 US claimed
JP-62067057-A None JP disclosed
US-8338465-B2 Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis CORNELL RESEARCH FOUNDATION, INC. (US) 2012-12-25 US disclosed
US-8338465-B2 Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis CORNELL RESEARCH FOUNDATION, INC. (US) 2012-12-25 US disclosed
EP-1923227-B1 A structure with a built-in recording medium, a laminate comprising the structure and method for recording in non-contact manner using the structure and the laminate LINTEC CORP (JP) 2011-05-11 EP disclosed
US-7939464-B2 Resin laminate material with a built-in recording medium with a means for rewriting visible information with a laser light in a non-contact manner; recording and erasing of information can be conducted by irradiation with a laser light from outside LINTEC CORPORATION (JP) 2011-05-10 US disclosed
US-20100210577-A1 CYCLIC CARBOXYLIC ACID RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS CORNELL RESEARCH FOUNDATION, INC. 2010-08-19 US disclosed
US-20100210577-A1 CYCLIC CARBOXYLIC ACID RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS CORNELL RESEARCH FOUNDATION, INC. 2010-08-19 US disclosed
US-20080193397-A1 Use of Peroxide Decomposers Method For the Treatment of a Material Other Than the Human Body BASF AKTIENGESELLSCAFT (DE) 2008-08-14 US disclosed
US-5041667-A Process for producing chlorophenylhydrazine compounds KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1991-08-20 US disclosed
EP-0208477-B1 PROCESS FOR PRODUCING CHLOROPHENYLHYDRAZINE COMPOUNDS KONICA CORPORATION (JP) 1989-03-15 EP disclosed
JP-S6267057-A PRODUCTION OF CHLOROPHENYLHYDRAZINE COMPOUND KONISHIROKU PHOTO IND CO LTD 1987-03-26 JP disclosed
EP-0208477-A1 Process for producing chlorophenylhydrazine compounds KONICA CORPORATION (JP) 1987-01-14 EP disclosed
US-4403051-A NONVISCOUS MIXTURE OF POLYVINYL ALCOHOL AND PULP KANZAKI PAPER MANUFACTURING COMPANY, LIMITED (JP) 1983-09-06 US disclosed
US-4180405-A COLOR-FORMING LACTONES OR SPIROPYRANS WITH CYCLIC POLYKETO COLOR PRECURSOR GRAPHIC CONTROLS CORPORATION (US) 1979-12-25 US disclosed
US-4097288-A Heat sensitive recording composition containing a complexed phenolics and a spiropyran or leuco lactone GRAPHIC CONTROLS CORPORATION 1978-06-27 US disclosed
US-4074050-A COLOR FORMER HODOGAYA CHEMICAL CO., LTD. (JA) 1978-02-14 US disclosed
US-4073614-A Mixture of benzoxazines and benzodioxanes which may be used as color formers HODOGAYA CHEMICAL CO., LTD. (JA) 1978-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193397-A1 Use of Peroxide Decomposers Method For the Treatment of a Material Other Than the Human Body GPX4, LPO, GPX1 MAPT 2926/4885GAA 1162/4885ALDH1A1 569/4885
US-20100210577-A1 CYCLIC CARBOXYLIC ACID RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS RARG, SDHA, RARS2 MAPT 3973/4885GAA 162/4885ALDH1A1 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.